Iron deficiency anemia and use of intravenous iron in digestive disease;Anemia ferropénica y uso de hierro endovenoso en patología digestiva

Gastroenterologia y Hepatologia

Volumn 33, Issue 8, 2010, Pages 605-613

  Mearin, Fermín ^a   Balboa, Agustín ^a   Castells, Antoni ^b   Domínguez, J Enrique ^c   Esteve, Maria ^d   García Erce, Jose A ^e   Pérez Gisbert, Javier ^f   Gomollón, Fernando ^g   Panés, Julián ^b   Ponce, Julio ^h  

^a CENTRO MÉDICO TEKNON   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c Instituto de Salud Carlos III   (Spain)

^d HOSPITAL MÚTUA DE TERRASSA   (Spain)

^e HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^f HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^g HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^h HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IRON;

ARTICLE; CELIAC DISEASE; DIGESTIVE SYSTEM CANCER; DIGESTIVE SYSTEM DISEASE; DIGESTIVE SYSTEM HEMORRHAGE; ENTERITIS; HUMAN; IRON DEFICIENCY ANEMIA; IRON METABOLISM;

EID: 77957320917     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2010.08.001     Document Type: Article

References (61)

1. Pérez G., Vittori D., Pregi N., Garbossa G., Nesse A. Homeostasis del hierro. Mecanismos de absorción, captación celular y regulación. Acta Bioquím Clín Latinoam 2005, 39:301-314.
2. Guralnik J.M., Eisenstaedt R.S., Ferrucci L., Klein H.G., Woodman R.C. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004, 104:2263-2268.
3. Moreno Chulilla J.A., Romero Colás M.S., Gutiérrez Martín M. Classification of anemia for gastroenterologists. World J Gastroenterol 2009, 15:4627-4637.
4. Vucelić D., Nenadić B., Pesko P., Bjelović M., Stojakov D., Sabljak P., et al. Iron deficiency anemia and its importance in gastroenterology clinical practise. Acta Chir Iugosl 2007, 54:91-105. (abstract).
5. Gisbert J.P., Gomollon F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol 2008, 103:1299-1307.
6. Gasche C., Berstad A., Befrits R., Beglinger C., Dignass A., Erichsen K., et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007, 13:1545-1553.
7. Bermejo F. ¿Realmente sirve para algo el hierro intravenoso en el tratamiento de la enfermedad inflamatoria intestinal? ¿No es más sencillo y más barato el hierro oral?. Gastroenterol Hepatol 2009, 32:63-64.
8. García-Erce J.A., Fernánde Pérez C., Rubio Félix D., Muñoz Gómez M. Balance riesgo-beneficio de los agentes eritropoyéticos frente a la transfusión. Anemia 2009, 2:136-142.
9. Muñoz Gómez M., Molero León S.E., García-Erce J.A. Fisiopatología del metabolismo del hierro y sus implicaciones en la anemia perioperatoria. Anemia 2008, 1:47-60.
10. García-Erce J.A., Muñoz Gómez M. Hepcidina: una molécula clave para explicar la fisiopatología de la anemia. GH Continuada 2008, 7:119-123.
11. Nemeth E., Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr 2006, 26:323-342.
12. Patel K.V. Epidemiology of anemia in older adults. Semin Hematol 2008, 45:210-217.
13. Gomollón F., Gisbert J.P. Anemia and digestive diseases: an update for the clinician. World J Gastroenterol 2009, 15:4615-4616.
14. Rasul I., Kandel G.P. An approach to iron-deficiency anemia. Can J Gastroenterol 2001, 15:739-747.
15. Goddard A.F., McIntyre A.S., Scott B.B. Guidelines for the management of iron deficiency anaemia. Gut 2000, 46(Suppl IV):IV1-IV5. for the British Society of Gastroenterlogy.
16. Toy E., Rojany M., Sheikh R., Mann S., Prindiville T. Capsule endoscopy's impact on clinical management and outcomes: a single-center experience with 145 patients. Am J Gastroenterol 2008, 103:3022-3028.
17. Rockey D.C. Hemorragia digestiva. Sleisenger y Fordtran. Enfermedades digestivas y hepáticas 2008, 255-299. Elsevier España, S.A., Madrid. 8.a ed. M. Feldman, L.S. Friedman, L.J. Brandt (Eds.).
18. Ballester R., Planella M., Teixidó M., Zaragoza N., Isava A., Ardèvol A., et al. Estudio prospective de la incidencia de anemia ferropénica post hemorragia digestive alta. Valoración de factores predictivos. Resultados preliminares. Gastroenterol Hepatol 2009, 32:245.
19. Gasche C., Lomer M.C., Cavill I., Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut 2004, 53:1190-1197.
20. Wilson A., Reyes E., Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med 2004, 116(Suppl 7A):44S-49S.
21. Kulnigg S., Gasche C. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 2006, 24:1507-1523.
22. Gomollón F., Gisbert J.P. Anemia and inflammatory bowel diseases. World J Gastroenterol 2009, 15:4659-4665.
23. Semrin G., Fishman D.S., Busvaros A., Zholudev A., Saunders A.C., Correia C.E., et al. Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis 2006, 12:1101-1106.
24. Halfdanarson T.R., Litzow M.R., Murray J.A. Hematologic manifestations of celiac disease. Blood 2007, 109:412-421.
25. Fernández-Bañares F., Monzón H., Forné M. A short review of malabsorption and anemia. World J Gastroenterol 2009, 15:4644-4652.
26. Harper J.W., Holleran S.F., Ramakrishnan R., Bhagat G., Green P.H. Anemia in celiac disease is multifactorial in etiology. Am J Hematol 2007, 82:996-1000.
27. Carroccio A., Iannitto E., Cavataio F., Montalto G., Tumminello M., Campagna P., et al. Sideropenic anemia and celiac disease: one study, two points of view. Dig Dis Sci 1998, 43:673-678.
28. Garrido C., Gaya J., Liompart A., Vaquer P., Sanso A., Riera J., et al. Prevalencia de enfermedad celíaca monosintomática en pacientes con anemia ferropénica. Gastroenterol Hepatol 1997, 20:172-174.
29. Raya Sánchez J.M. Déficit de hierro sin pérdidas hemorrágicas evidentes: ¿un "reto" para la práctica clínica?. An Med Interna (Madrid) 2003, 20:225-226.
30. Rostom A., Murray J.A., Kagnoff M.F. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006, 131:1981-2002.
31. Zamani F., Mohamadnejad M., Shakeri R., Amiri A., Najafi S., Alimohamadi S.M., et al. Gluten sensitive enteropathy in patients with iron deficiency anemia of unknown origin. World J Gastroenterol 2008, 14:7381-7385.
32. Diagnóstico precoz de la enfermedad celiaca. Ministerio de Sanidad y Consumo; 2008.
33. Castells A., Pique J.M. Tumores del intestino. Medicina ínterna 2004, 229-240. Elsevier, Madrid. 15.a ed. V. Farreras, C. Rozman (Eds.).
34. Littlewood T.J., Alikhan R. The use of intravenous iron in patients with cancer-related anaemia. Br J Haematol 2008, 141:751-756.
35. Clinical Pancreatology for Practising Gastroenterologists and Surgeons 2005, Oxford, Blackwell-Publishing. J.E. Domínguez-Muñoz (Ed.).
36. Juncàpiera J. Actualización de la ferroterapia parenteral. Med Clin (Barc) 2004, 123:300-302.
37. Lyseng-Williamson K.A., Keating G.M. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. Drugs 2009, 69:739-756.
38. Raju G.S., Gerson L., Das A., Lewis B. American Gastroenterological Association (AGA) Institute Technical Review on obscure gastrointestinal bleeding. Gastroenterolgy 2007, 133:1697-1717.
39. Maslovsky I. Intravenous iron in a Primary-Care Clinic. Am J Hematol 2005, 78:261-264.
40. Goddard AF, James MW, McIntyre AS, Scout BB on behalf of the BSG. Guidelines for the management of iron deficiency anaemia. British Society of Gastroenterology 2005. Guidelines in Gastroenterology 16.
41. Schröder O., Schrott M., Blumenstein I., Jahnel J., Dignass A.U., Stein J. A study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anaemia due to gastrointestinal bleeding. Z Gastroenterol 2004, 42:663-667.
42. Van Wyck D.B., Martens M.G., Seid M.H., Baker J.B., Mangione A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia. A randomized controlled trial. Obstet Gynecol 2007, 110:267-278.
43. Gordon S.S., Hadley P.E., Van Wyck D.B. Iron carboxymaltosa, a new intravenous iron agent for iron deficiency anemia in heavy uterine bleeding. Obstet Gynecol 2007, 109(Supl 4):108S.
44. Al R.A., Unlubilgin E., Kandemir O., Yalvac S., Cakir L., Haberal A. Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial. Obstet Gynecol 2005, 106:1335-1340.
45. Muñoz M., Gómez-Ramírez S., García-Erce J.A. Intravenous iron in inflammatory bowel disease. World J Gastroenterol 2009, 15:4666-4674.
46. De la Morena F., Gisbert J.P. Anemia and inflammatory Bowel Disease. Rev Esp Enf Dig 2008, 100:285-293.
47. Gisbert J.P., Bermejo F., Pajares R., Pérez-Calle J.L., Rodríguez M., Algaba A., et al. Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement. Inflamm Bowel Dis 2009, 15:1485-1491.
48. Erichsen K., Ulvik R.J., Nysaeter G., Johansen J., Ostborg J., Berstad A., et al. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scand J Gastroenterol 2005, 40:1058-1065.
49. Schröder O., Mickisch O., Seidler U., de Weerth A., Dignass A.U., Herfarth H., et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study. Am J Gastroenterol 2005, 100:2503-2509.
50. Lindgren S., Wikman O., Befrits R., Blom H., Eriksson A., Granno C., et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol 2009, 1-8.
51. Kulnigg S., Stoinov S., Simanenkov V., Dudar L.V., Karnafel W., Garcia L.C., et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol 2008, 103:1182-1192.
52. Annibale B., Severi C., Chistolini A., Antonelli G., Lahner E., Marcheggiano A., et al. Efficacy of gluten-free diet alone on recovery from iron deficiency anemia in adult celiac patients. Am J Gastroenterol 2001, 96:132-137.
53. Lanzini A., Lanzarotto F., Villanacci V., Mora A., Bertolazzi S., Turini D., et al. Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten free diet. Aliment Pharmacol Ther 2009, 29:1299-1308.
54. Malamut G., Afchain P., Verkarre V., Lecomte T., Amiot A., Damotte D., et al. Presentation and long-term follow-up of refractory celiac disease: Comparison of type I with type II. Gastroenterology 2009, 13:81-90.
55. Wu W.C., Schifftner T.L., Henderson W.G., Eaton C.B., Poses R.M., Uttley G., et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007, 297:2481-2488.
56. Muñoz N., Campos A., García-Erce J.A. Intravenous Iron in Colorectal Cancer Surgery. Semin Hematol 2006, 34(Suppl 6):S36-S38.
57. Beris P., Munoz M., Garcia-Erce J.A., Thomas D., Maniatis A., Van der Linden P. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008, 100:599-604.
58. Muñoz M., García-Erce J.A., Díez-Lobo A.I., Campos A., Sebastianes C., Bisbe E. Utilidad de la administración de hierro sacarosa intravenoso para la corrección de la anemia preoperatoria en pacientes programados para cirugía mayor. Med Clin (Barc) 2009, 132:303-306.
59. Muñoz M., García-Erce J.A., Gómez-Ramírez S., Fernández-Pérez C. Papel del hierro endovenoso en la anemia relacionada con el cáncer. Anemia 2009, 2:143-148.
60. Pedrazzoli P., Farris A., Del Prete S., Del Gaizo F., Ferrari D., Bianchessi C., et al. Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha. J Clin Oncol 2008, 26:1619-1625.
61. Bastit L., Vandebroek A., Altintas S., Gaede B., Pintér T., Suto T.S., et al. Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia. J Clin Oncol 2008, 26:1611-1618.